Cite
HARVARD Citation
Kim, S. et al. (n.d.). O030/#339 Primary cytoreductive surgery leads to improved survival in patients with advanced ovarian cancer with brca germline or somatic mutation. International journal of gynecological cancer. p. A19. [Online].